Enterococcus faecalis is a human intestinal pathobiont with intrinsic and acquired resistance to 28 many antibiotics, including vancomycin. Nature provides a diverse and virtually untapped repertoire of 29 bacterial viruses, or bacteriophages (phages), that could be harnessed to combat multi-drug resistant 30 enterococcal infections. Bacterial phage resistance represents a potential barrier to the implementation 31 of phage therapy, emphasizing the importance of investigating the molecular mechanisms underlying the 32 emergence of phage resistance. Using a cohort of 19 environmental lytic phages with tropism against E. 33 faecalis, we found that these phages require the enterococcal polysaccharide antigen (Epa) for 34 productive infection. Epa is a surface-exposed heteroglycan synthesized by enzymes encoded by both 35 conserved and strain specific genes. We discovered that exposure to phage selective pressure favors 36 mutation in non-conserved epa genes both in culture and in a mouse model of intestinal colonization. 37
The utility of phages as effective anti-enterococcal therapeutics relies on having a detailed 79 understanding of phage infection mechanisms and how enterococci subvert phage infection through the 80 development of resistance. To date, only a single membrane protein, PIPEF (phage infection protein of E. 81 faecalis), has been definitively identified as a phage receptor for E. faecalis (15) . The enterococcal 82 polysaccharide antigen (Epa) is involved in phage adsorption to E. faecalis cells and may act as a phage 83 receptor (16) (17) (18) . Considering at least a dozen well-characterized lytic enterococcal phages have the 84 potential to be used for phage therapy (11), identifying receptors used by phages could allow for the 85 generation of more efficient phage cocktails to be used for the treatment of enterococcal infections. This 86 is particularly important since phage therapies can employ the use of multivalent phage cocktails to limit 87 the emergence of bacterial resistance (19, 20) and knowledge of phage receptors can lead to rational 88 design of such cocktails. In addition, phages often target conserved components of the bacterial cell 89 surface, which bacteria can mutate to subvert phage infection. If a phage receptor is essential to bacterial 90 physiology, mutation often imposes a fitness cost (21) (22) (23) . Therefore, therapeutic phages could be 91 selected that force bacterial targets to trade a fitness benefit in return for phage resistance, making them 92 less pathogenic and possibly more susceptible to current antimicrobials (21, 24) . 93
The E. faecalis genome contains both broadly conserved and strain variable epa genes (25) . 94
Using E. faecalis and a collection of uncharacterized virulent phages, we identify genes located in the 95 variable region of the epa locus to be critical for phage infection. Epa is directly involved in phage 96 attachment to the bacterial surface. Exposure of E. faecalis to certain phages, both in vitro and in the 97 mouse intestine, selects for mutations in the epa locus, primarily in epa variable genes. Loss of function 98 mutations in two epa variable genes, epaS and epaAC, resulted in cell surface alterations that increase 99 the sensitivity of E. faecalis to cell wall targeting antibiotics. During colonization of the mouse intestine, 100 an E. faecalis epaS mutant had a colonization defect in both adult mice and juvenile mice shortly following 101 birth. The epaS mutant also failed to efficiently outgrow in the intestine upon antibiotic mediated 102 perturbation of the native commensal bacteria. Together these data suggest that during enterococcal using both broad (phi4, phi17, phi19) and narrow (phi47, phi51) host range phages, using E. faecalis 133 strains V583 (phi4, phi17, phi19), SF28073 (phi47) and X98 (phi51) ( Table S1 ). Phages were mixed with 134 E. faecalis in top agar, poured over the surface of an agar plate, and assayed for confluent lysis. Potential 135 phage resistant colonies emerged within zones of lysis after overnight incubation. The spot-agar assay 136 was used to confirm phage resistance of the isolates (Fig. 1B-D) . 137
We next determined the extent of phage cross-resistance by testing the E. faecalis phage 138 resistant isolates against all other phages in the NMRC collection ( Fig. 1B-D) . Our data show that 139 regardless of the phage used to select for resistance, there is broad cross-resistance to other phages 140 from the collection ( Fig. 1B-D) . These data suggest that even though NMRC phages have distinct host 141 tropisms they likely infect through a related mechanism. 142 143
Mutations in enterococcal polysaccharide antigen (epa) genes promote phage resistance 144
To determine the genetic basis of PIPEF-independent lytic phage infection in E. faecalis, we 145 performed whole genome sequencing of select spontaneous phage resistant mutants and their 146 corresponding wild type parental strains. In all cases, no matter which phage was used to select for 147 resistance, phage resistant isolates harbored mutations in the enterococcal polysaccharide antigen (epa) 148 gene cluster (Table 1, Fig. 4A ), implicating epa mutation as a key contributor to phage resistance. 149
The epa locus encodes genes involved in the biosynthesis of a rhamnose containing cell surface 150 associated polysaccharide (30), yet the biochemical functions of most Epa proteins are uncharacterized. 151
The E. faecalis epa gene cluster ( Fig. 4A ) consists of a conserved core set of 18 genes (epaA -epaR) 152 upstream a group of variable genes beginning at epaS (EF2176 in V583) and ending at epaAC (EF2165 153 in V583) (17, 25) . epaR, encoding a transmembrane glycosyltransferase, was the only core gene found 154 to be mutated (Table S1 ). This is consistent with a recent study demonstrating that mutation of epaR in 155 in the phage resistant isolates mapped to variable region epa genes including epaS, epaW, epaX and 157 epaAC ( Fig. 4A , 4B, and Table S1 ). Notably, epaX was recently found to aid in the adsorption of the 158
Podoviridae phage Idefix (18). 159
Since E. faecalis is a native inhabitant of the intestine, we determined whether phage driven epa 160 mutations arose in germ free C57BL6/J mice colonized with the E. faecalis strains V583 or SF28073. 161
Mice were treated orally with 10 10 pfu of phi4 or phi47 for seven days, after which bacteria were isolated 162 from the feces and screened for phage resistance by plating on agar plates containing either phi4 or 163 phi47. We sequenced six E. faecalis V583 isolates resistant to phi4 and ten E. faecalis SF28073 isolates 164 resistant to phi47. Similar to the phage resistant isolates acquired in vitro, all in vivo phage resistant 165 isolates had mutations that mapped to the epa locus (Table S2 ). Mutations were restricted to epaR and 166 epaS in the E. faecalis SF28073 resistant isolates. Two of the six E. faecalis phi4 resistant isolates in the 167 V583 background had mutations that mapped to epaX and epaAC. The remaining four isolates had 168 mutations that mapped to epaY (Table S2) . Interestingly, no epaY mutations were found in any of 16 in 169 vitro derived epa specific phage resistant isolates (Table S1 ), suggesting that in vivo phage selective 170 pressure may be directed toward alternative epa variable genes. 171
Previous studies have demonstrated that core epa genes are important for phage infection of E. 172 faecalis (16-18). To confirm the role of epa variable genes in facilitating phage infection of the NMRC 173 phages, we generated in-frame deletion mutants of epaS and epaAC in E. faecalis V583 using allelic 174 replacement. The mutants achieved a slightly lower overall culture density in the stationary phase (Fig. 175 4D) but had a similar doubling time during logarithmic growth compared to wild type E. faecalis V583 (31 176 min -wild type, 35 min -∆epaS, 33 min -∆epaAC). We attempted to make unmarked deletions in epaX 177 and epaW, however, we were unable to generate these mutant strains. Because epa mutations resulted 178 in widespread resistance of E. faecalis to many of the phages in the NMRC collection ( Fig. 1B) , we chose 179 to confirm these isogenic mutants using phi4. As judged by bacterial growth on agar plates containing 8 from the spontaneous phage resistant isolates 4RS4 and 4RS9, respectively ( Fig. 4B and 4C ). phi4 182 susceptibility could be restored by complementation ( Fig. 4B and 4C ). Together, these data indicate that 183 the loss-of-function of epaS and epaAC alone are sufficient to confer phage resistance. 184 185
Epa dictates phage adsorption but not phage infectivity of E. faecalis. 186
To investigate how Epa contributes to phage infection, we tested the ability of phages to adsorb 187 to phage resistant or wild type E. faecalis cells. phi4 adsorption was higher for wild type E. faecalis V583 188 compared to the epa mutant isolates 4RS4, 4RS9, 17RS5, 19RS21 and 19RS28 ( Fig. 5A ). Consistent 189 with this observation, in frame deletion of epaS or epaAC abrogated the adsorption of phi4 to E. faecalis 190 ( Fig. 5A ). These data indicate that Epa cell wall modification is essential for phage adsorption. 191
We next assessed whether susceptibility to infection by specific phages is dictated by the ability 192 of phages to adsorb to the surface of E. faecalis cells. phi4 adsorbed to both cognate (V583, X98 and 193 SF28073) and non-cognate (CH188 and ATCC4200) E. faecalis cells ( Fig. 5B) . Similarly, phi47 adsorbed 194 to E. faecalis SF28073 and adsorbed with ~60-80% efficiency to strains that it does not infect (V583, 195 CH188 and ATCC4200) ( Fig. 5C and Fig. 1A ). To determine if the promiscuous adsorption observed for 196 phi4 and phi47 was restricted to E. faecalis, we tested the ability of these phages to adsorb to the related 197 enterococcal species E. faecium. Greater than 50% of phi4 and phi47 phage particles adsorbed to E. 198 faecium strains Com12, Com15 and 1141733 ( Fig. 5D -5E ). E. faecium harbors an epa locus which 199 resembles the epa locus of E. faecalis (25) . From these data we conclude that Epa is important for 200 primary phage adsorption prior to infection. Considering phages phi4 and phi47 adsorb to strains that are 201 naturally resistant to infection or killing, suggests that either abortive infection drives this resistance or an 202 unidentified receptor required for DNA entry dictates phage infectivity. 203
epa variable gene mutations increase susceptibility to cell wall targeting antibiotics and alter cell 205 surface properties 206
Previous work showed that mutation of the genes epaI, epaR and epaOX (epaX in strain V583), 207 increase the susceptibility of E. faecalis OG1RF to the cell membrane specific antibiotic daptomycin (16, 208 31) . We sought to determine if the loss of epa variable genes, epaS and epaAC, conferred similar 209 enhanced sensitivity to cell wall targeting antibiotics. To test this, we compared the sensitivity of wild type 210 E. faecalis V583 and isogenic epaS and epaAC mutants to daptomycin and vancomycin. We chose to 211 assess vancomycin sensitivity because its mechanism of action targets cell wall biosynthesis and E. 212 faecalis V583 is vancomycin resistant (32). The epaS mutant showed increased susceptibility to both 213 vancomycin and daptomycin compared to wild type E. faecalis V583 ( Fig. 6A and 6B ). To a lesser extent 214 the epaAC mutant also showed increased susceptibility to both antibiotics albeit at concentrations higher 215 than those observed for the epaS mutant ( Fig. 6C and 6D ). These data indicate that similar to other epa 216 genes, epaS and epaAC play a role in the structural integrity of the E. faecalis cell wall during antibiotic 217
pressure. 218
Epa mutations likely result in modified cell wall anchored sugar composition (16, 17) . To 219 determine if these modifications influence the overall charge of the E. faecalis cell wall, we performed a 220 protein binding assay using the cationic protein cytochrome c (33). Cytochrome c bound less to the epaS 221 and epaAC mutants compared to the wild type strain (Fig. S1 ). Complementation restored cytochrome c 222 binding to wild type levels ( Fig. S1 ). These data suggest that the cell wall of the epaS and epaAC mutants 223 has a greater net positive charge compared to wild type E. faecalis V583, confirming that loss of function 224 mutations in the epa variable genes influence cell surface charge. 225
226

EpaS supports colonization and antibiotic mediated expansion of intestinal E. faecalis 227
Recently, Rigottier-Gois et al (34) reported that mutation of the E. faecalis epa variable gene 228 epaX, encoding a group 2 glycosyltransferase domain protein, results in an intestinal colonization defect 229 in mice. EpaS also contains a group 2 glycosyltransferase domain. Therefore, we tested whether an 230 epaS deletion strain has an intestinal colonization defect. Groups of conventional C57BL6/J mice were by addition of the bacteria to the drinking water for 18 days (Fig. 7A ). On day 18 the mice were given 233 bacteria-free water and the E. faecalis colonization levels were monitored for 10 days. Both the wild type 234 and epaS mutant established persistent colonization over the 10 day period (Fig. 7B ). However, 235 beginning three days post removal of bacteria from the drinking water (day 21), the epaS mutant 236 colonized ~33-fold lower than wild type E. faecalis V583 (Fig. 7B ). Thus, similar to epaX, epaS is a 237 colonization factor. This also suggests that Epa glycosyltransferases are critical for intestinal colonization. 238
Enterococcal intestinal dysbiosis has been linked to antibiotic use in humans and these individuals 239 are at increased risk of developing enterococcal blood stream infections (3, 35) . Having observed that 240 the epaS mutant is more susceptible to vancomycin treatment in vitro (Fig. 6A) , we asked whether 241 functional EpaS would be beneficial during antibiotic mediated E. faecalis expansion in the intestine. To 242 test this, we performed an experiment identical to that described in Fig. 7B , except that starting on day 243 21 the mice were gavaged with 100 µg of vancomycin daily for four days (Fig. 7C ). Immediately following 244 the first dose of vancomycin, mice colonized with wild type E. faecalis V583 experienced a 4-log increase 245 in E. faecalis colonization compared to mice colonized with the epaS mutant strain (Fig. 7C ). During the 246 course of vancomycin treatment, the epaS mutant remained at a colonization level significantly lower 247 level than wild type E. faecalis V583. Three days post vancomycin treatment we observed a slight bloom 248 of the epaS mutant; however, the epaS mutant did not achieve a similar level of colonization compared 249 to wild type E. faecalis V583. We hypothesize that this bloom may be due to vancomycin mediated killing 250 of commensal bacteria, freeing up previously occupied niches that allow the epaS mutant to expand its 251 population. Considering the epaS mutant strain does not rebound to the same levels as wild type E. 252 faecalis V583 following vancomycin treatment, these data show that antibiotic induced intestinal 253 expansion of the enterococci requires functional EpaS. 254 255
EpaS is required for successful transmission of E. faecalis to newborn mice 256
Studies suggest that offspring acquire commensal E. faecalis from mother's breastmilk and the ability of antibiotic resistant E. faecalis to transmit to and colonize the intestine following birth. Therefore, 259
we tested the ability of wild type E. faecalis V583 and the isogenic epaS mutant strain to be transmitted 260 to naïve mouse pups born to mothers colonized with the bacteria. Female C57BL6/J mice were 261 impregnated while continuously exposed to wild type E. faecalis V583 or the epaS mutant in their drinking 262 water. After 21 days of bacterial exposure, the pregnant mothers were switched to clean water. The 263 mothers littered their pups within 5-8 days after transitioning to bacteria-free drinking water. Mothers were 264 chronically colonized for the duration of the experiment, however, the epaS mutant was maintained at a 265 lower level relative to the wild type E. faecalis V583 (Fig. S2 ). After weaning (3 weeks post birth), we 266 determined the levels of wild type E. faecalis V583 and the epaS mutant in the feces of the pups. 267
Recovery of wild type E. faecalis V583 from the pups was significantly higher in comparison to the epaS 268 mutant ( Fig. 8 ). Therefore, our data suggest that EpaS is an important factor for the colonization and 269 transmission of E. faecalis to newborns. patients could be prevented using phage therapy. More broadly, our data suggest that phages could be 284 used to exploit the evolution of bacterial phage resistance as an adjuvant to antibiotic therapy, in cases 285 where acquisition of phage resistance leads to new antibiotic sensitivities. 286
Bacterial surface polysaccharides directly interact with mammalian host surfaces and are key 287 virulence factors (17, 34, (37) (38) (39) (40) (41) . Previous studies identified glucose, rhamnose, N-acetylglucosamine, 288 N-acetyl galactosamine, and galactose as major components of Epa (17, 34); however, there are gaps 289 in our understanding of the Epa cell surface architecture. Epa is produced through the action of 290 biosynthetic enzymes encoded by select core genes residing in epaA-epaR (17, 34, 42) . It is less clear 291 how the genes in the variable region contribute to overall Epa composition. We discovered that the ability 292 of phages to infect E. faecalis is mediated through Epa. Specifically, mutations in the core gene epaR 293 and/or variable region genes including epaS, epaW, epaX, epaY and epaAC were sufficient to abrogate 294 phage infection. Recently, it was discovered that mutation of epaR and epaX in E. faecalis prevented 295 phage infection by excluding phage adsorption (16, 18) . Here, we found that modifications made by epa 296 variable genes are important for initial phage adsorption, although adsorption does not always lead to 297 successful phage infection. 298
Phage infection occurs in three distinct stages: phage adsorption, host receptor engagement and 299 phage DNA replication. Considering the phages from our study adsorb to non-susceptible bacterial 300 strains, it is likely that non-cognate hosts either have an incompatible cognate receptor, lack the required 301 phage receptor, or abort phage DNA replication. It is curious that all 32 phage resistant isolates reported 302 in this study harbored mutations only in epa genes. This observation, combined with the knowledge that 303 the phages adsorb to non-cognate host strains, indicates that E. faecalis preferentially subverts phage 304 infection by mutating epa. We hypothesize that another factor is required for productive phage infection. 305
This second factor is likely a bonafide phage receptor that facilitates DNA entry and may be an essential 306 protein, as only epa mutations arose in phage resistant E. faecalis isolates. We propose that Epa is the 307 attachment factor that positions phages in proximity of an unidentified receptor required for DNA ejection. 308
Previous studies have demonstrated that inactivation of core epa genes in E. faecalis affect 309 bacterial fitness (16, 17) . However, we have a limited understanding of the contribution of epa variable genes in this context. Similar to a recent report that an epaX mutant strain of E. faecalis has an intestinal 311 colonization defect (34), we demonstrated that an epaS mutant strain is also impaired in intestinal 312 colonization. Importantly, we show that epaS is a colonization determinant within the context of an 313 unperturbed microbiota. This shows that Epa cell surface decorations help E. faecalis compete in a 314 complex microbial community. In addition, an epaS mutant was impaired in its ability to transfer from 315 mother to infant and establish productive colonization. Considering enterococci are life-long colonizers 316 of humans and animals, this observation raises interesting questions about whether enterococci are 317 transferred directly from mother to infant or if they are acquired from the environment following birth. 318 E. faecalis intestinal adaptation is facilitated by its inherent resistance to environmental stressors 319 encountered in the mammalian gut such as low pH, high osmolarity and bile salts (16, 31, (43) (44) (45) . 320 Therefore, Epa likely plays a critical role in the survival of E. faecalis when encountering intestinal 321 environmental stresses. epa genes aid in the ability of E. faecalis to tolerate environmental stress which 322 is demonstrated by phage resistance and susceptibility to cell wall targeting antibiotics upon loss of 323 functional epa genes. When challenged with vancomycin, an epaS mutant of E. faecalis in the mouse 324 intestine lacks the ability to efficiently expand its population when bacterial diversity is diminished. These 325 data suggest that the epaS mutant cannot tolerate vancomycin selection and remains a minority member 326 of the microbiota. 327
In conclusion, we believe that phages like those described in this study are candidates for the 328 development of straightforward therapeutics that could be used in conjunction with current antibiotic 329 therapies to curtail the overgrowth of multidrug-resistant enterococci in vulnerable patients. We also 330 believe that these data emphasize the importance of understanding phage infection mechanisms for the 331 future development of phage cocktails. This information could help reduce the risk of developing phage 332 resistance during therapy. Colonization of conventional mice with either wild type E. faecalis V583 or the isogenic epaS mutant 568 strain. At day 21 (indicated with an arrowhead), following the introduction of bacteria-free water, the mice 569 were orally treated with 100 µg of vancomycin daily for four days. The dashed horizontal lines in (B) and 570 (C) indicates the limit of detection based on the bacterial plating procedure. *p<0.04, **p<0.008 by 
